Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

Historical Holders from Q2 2016 to Q3 2025

Symbol
CLSD
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
77M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
115K
Holdings value
$447K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
3
Number of buys
1
Number of sells
-42
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WHITMORE BRADFORD T 8.6% $5.48M 6.52M WHITMORE BRADFORD T 31 Dec 2024
Wiles Stephen Boyd 5.2% $3.36M 4M Stephen Boyd Wiles 31 Mar 2025

Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 115K $447K -$11.8M $3.97 3
2025 Q2 9.39M $7.51M +$449K $0.80 44
2025 Q1 8.81M $8.09M -$577K $0.92 44
2024 Q4 9.44M $8.97M -$10.8M $0.95 44
2024 Q3 10.1M $22.7M -$4.79M $1.27 49
2024 Q2 13.8M $17.9M -$2.36M $1.30 49
2024 Q1 15.5M $23.8M +$12M $1.53 52
2023 Q4 7.75M $9.06M +$2.01K $1.17 46
2023 Q3 7.84M $6.82M -$748K $0.87 45
2023 Q2 8.59M $9.62M -$244K $1.12 53
2023 Q1 8.73M $9.08M -$467K $1.04 48
2022 Q4 9.13M $10.2M -$824K $1.12 52
2022 Q3 12.1M $13.6M -$1.86M $1.13 48
2022 Q2 13.7M $20.1M -$4.12M $1.47 49
2022 Q1 16.4M $37.5M -$12.6M $2.29 58
2021 Q4 21M $57.8M -$3.76M $2.75 63
2021 Q3 20.3M $122M +$4.44M $6.00 64
2021 Q2 19.7M $95.8M +$478K $4.87 52
2021 Q1 16.9M $41.8M +$8.59M $2.47 50
2020 Q4 14.3M $39.1M +$4.32M $2.74 39
2020 Q3 12M $18.4M -$35.5K $1.54 40
2020 Q2 11.8M $22.2M +$477K $1.88 44
2020 Q1 11.5M $19.5M +$5.93M $1.70 41
2019 Q4 7.94M $23M +$2.76M $2.90 44
2019 Q3 6.99M $4.4M +$1.25M $0.63 29
2019 Q2 4.51M $4.38M -$1.79M $0.97 42
2019 Q1 6.13M $8.46M -$8.17M $1.38 54
2018 Q4 12.8M $13.7M -$30.8M $1.07 66
2018 Q3 18.5M $114M -$22.9M $6.15 86
2018 Q2 20.4M $218M +$7.95M $10.69 83
2018 Q1 19.6M $211M +$82.1M $10.73 79
2017 Q4 12.3M $86.3M -$5.57M $7.00 52
2017 Q3 13.1M $114M -$1.66M $8.74 49
2017 Q2 13.3M $121M +$12.5M $9.11 51
2017 Q1 12M $95.2M +$3.3M $7.94 58
2016 Q4 11.9M $106M +$35.2M $8.94 62
2016 Q3 7.93M $138M +$10.5M $17.35 30
2016 Q2 7.53M $52.8M +$52.8M $7.01 16